Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
J Clin Invest ; 125(10): 3782-94, 2015 Oct 01.
Article in English | MEDLINE | ID: mdl-26426077

ABSTRACT

Primary pain and touch sensory neurons not only detect internal and external sensory stimuli, but also receive inputs from other neurons. However, the neuronal derived inputs for primary neurons have not been systematically identified. Using a monosynaptic rabies viruses-based transneuronal tracing method combined with sensory-specific Cre-drivers, we found that sensory neurons receive intraganglion, intraspinal, and supraspinal inputs, the latter of which are mainly derived from the rostroventral medulla (RVM). The viral-traced central neurons were largely inhibitory but also consisted of some glutamatergic neurons in the spinal cord and serotonergic neurons in the RVM. The majority of RVM-derived descending inputs were dual GABAergic and enkephalinergic (opioidergic). These inputs projected through the dorsolateral funiculus and primarily innervated layers I, II, and V of the dorsal horn, where pain-sensory afferents terminate. Silencing or activation of the dual GABA/enkephalinergic RVM neurons in adult animals substantially increased or decreased behavioral sensitivity, respectively, to heat and mechanical stimuli. These results are consistent with the fact that both GABA and enkephalin can exert presynaptic inhibition of the sensory afferents. Taken together, this work provides a systematic view of and a set of tools for examining peri- and extrasynaptic regulations of pain-afferent transmission.


Subject(s)
Afferent Pathways/physiology , Efferent Pathways/physiology , Nerve Net/physiology , Nociception/physiology , Sensory Receptor Cells/physiology , Spinal Cord Dorsal Horn/cytology , Animals , Defective Viruses/physiology , Enkephalins/physiology , Forelimb/innervation , GABAergic Neurons/physiology , GABAergic Neurons/virology , Ganglia, Spinal/cytology , Hyperalgesia/physiopathology , Interneurons/physiology , Interneurons/virology , Nerve Tissue Proteins/analysis , Neural Conduction , Neurons, Afferent/physiology , Neurons, Afferent/virology , Neurons, Efferent/physiology , Neurons, Efferent/virology , Nociceptors/physiology , Posterior Horn Cells/physiology , Posterior Horn Cells/virology , Presynaptic Terminals/physiology , Rabies virus/physiology , Sensory Receptor Cells/classification , Sensory Receptor Cells/virology , Skin/innervation , Spinal Cord Dorsal Horn/physiology , Spinal Cord Dorsal Horn/ultrastructure , Virus Replication , gamma-Aminobutyric Acid/physiology
2.
J Vis Exp ; (73): e50313, 2013 Mar 18.
Article in English | MEDLINE | ID: mdl-23542888

ABSTRACT

Intraparenchymal injection of a viral vector enables conditional gene manipulation in distinct populations of neurons or particular regions of the central nervous system. We demonstrate a stereotaxic injection technique that allows targeted gene expression or silencing in the dorsal horn of the mouse spinal cord. The surgical procedure is brief. It requires laminectomy of a single vertebra, providing for quick recovery of the animal and unimpaired motility of the spine. Controlled injection of a small vector suspension volume at low speed and use of a microsyringe with beveled glass cannula minimize the tissue lesion. The local immune response to the vector depends on the intrinsic properties of the virus employed; in our experience, it is minor and short-lived when a recombinant adeno-associated virus is used. A reporter gene such as enhanced green fluorescent protein facilitates monitoring spatial distribution of the vector, and the efficacy and cellular specificity of the transfection.


Subject(s)
Adenoviridae/genetics , Gene Transfer Techniques , Genetic Vectors/administration & dosage , Spinal Cord/physiology , Stereotaxic Techniques , Animals , Cytomegalovirus/genetics , Green Fluorescent Proteins/biosynthesis , Green Fluorescent Proteins/chemistry , Green Fluorescent Proteins/genetics , Laminectomy , Mice , Microinjections/instrumentation , Microinjections/methods , Posterior Horn Cells/physiology , Posterior Horn Cells/virology , Promoter Regions, Genetic , Spinal Cord/surgery , Spinal Cord/virology
3.
Neuroscience ; 150(2): 459-66, 2007 Dec 05.
Article in English | MEDLINE | ID: mdl-17997045

ABSTRACT

We investigated using the mice role of nitric oxide synthase (NOS) in the spinal dorsal horn in herpetic and postherpetic pain, especially allodynia, which was induced by transdermal inoculation of the hind paw with herpes simplex virus type-1 (HSV-1). The virus inoculation induced NOS2 expression in the lumbar dorsal horn of mice with herpetic allodynia, but not postherpetic allodynia. There were no substantial alternations in the expression level of NOS1 at the herpetic and postherpetic stages. Herpetic allodynia was significantly inhibited by i.p. administration of the selective NOS2 inhibitor S-methylisothiourea, but not the selective NOS1 inhibitor 7-nitroindazole. NOS2 expression was observed around HSV-1 antigen-immunoreactive cells. On the other hand, postherpetic allodynia was significantly inhibited by i.p. administration of 7-nitroindazole, but not S-methylisothiourea. The activity of reduced nicotinamide adenine dinucleotide phosphate diaphorase, an index of NOS1 activity, significantly increased in the laminae I and II of the lumbar dorsal horn of mice with postherpetic allodynia, but not mice without postherpetic allodynia. The expression level of NOS1 mRNA in the dorsal root ganglia was similar between mice with and without postherpetic allodynia. The results suggest that herpetic and postherpetic allodynia is mediated by nitric oxide in the dorsal horn and that NOS2 and NOS1 are responsible for herpetic and postherpetic allodynia, respectively. It may be worth testing the effects of NOS2 and NOS1 inhibitors on herpetic pain and postherpetic neuralgia in human subjects, respectively.


Subject(s)
Ganglia, Spinal/enzymology , Neuralgia, Postherpetic/enzymology , Neuralgia, Postherpetic/physiopathology , Nitric Oxide Synthase Type II/metabolism , Nitric Oxide Synthase Type I/metabolism , Nitric Oxide/biosynthesis , Posterior Horn Cells/enzymology , Animals , Dihydrolipoamide Dehydrogenase/metabolism , Enzyme Inhibitors/pharmacology , Enzyme Inhibitors/therapeutic use , Female , Ganglia, Spinal/physiopathology , Ganglia, Spinal/virology , Herpesvirus 1, Human/physiology , Hyperalgesia/enzymology , Hyperalgesia/physiopathology , Hyperalgesia/virology , Indazoles/pharmacology , Isothiuronium/analogs & derivatives , Isothiuronium/pharmacology , Mice , Mice, Inbred C57BL , Nitric Oxide Synthase Type I/antagonists & inhibitors , Nitric Oxide Synthase Type I/genetics , Nitric Oxide Synthase Type II/antagonists & inhibitors , Nitric Oxide Synthase Type II/genetics , Nociceptors/enzymology , Nociceptors/physiopathology , Nociceptors/virology , Posterior Horn Cells/physiopathology , Posterior Horn Cells/virology , RNA, Messenger/metabolism , Up-Regulation/physiology
4.
J Neurovirol ; 13(3): 260-7, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17613716

ABSTRACT

This study investigated the role of human T-cell lymphotropic virus type I HTLV-I infection in 11 patients who developed slowly progressive myelopathy with abnormal spinal cord lesions. The authors performed clinical and neuroradiological examinations and calculated the odds that an HTLV-I-infected individual of a specific genotype, age, and provirus load has HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Anti-HTLV-I antibodies were present in both the serum and cerebrospinal fluid in all of the patients. Abnormal magnetic resonance imaging (MRI) lesions were classified as cervical to thoracic type (CT type), cervical type (C type), and thoracic type (T type). In each type, there was swelling of the spinal cords with high-intensity lesions, which were located mainly in bilateral posterior columns, posterior horns, or lateral columns. Virological and immunological analyses revealed that all patients showed a high risk of developing HAM/TSP. These 11 patients may have developed HAM/TSP, as manifested by spinal cord abnormalities shown on MRI. These MRIs implicate clinical variability of HAM/TSP, which may indicate active-early stages of HAM/TSP lesions.


Subject(s)
Human T-lymphotropic virus 1/isolation & purification , Magnetic Resonance Imaging , Myelitis/pathology , Myelitis/virology , Paraparesis, Tropical Spastic/pathology , Aged , Antibodies, Viral/blood , Antibodies, Viral/cerebrospinal fluid , Cervical Vertebrae , Edema/pathology , Edema/virology , Female , Human T-lymphotropic virus 1/immunology , Humans , Male , Middle Aged , Paraparesis, Tropical Spastic/immunology , Posterior Horn Cells/pathology , Posterior Horn Cells/virology , Thoracic Vertebrae
SELECTION OF CITATIONS
SEARCH DETAIL
...